CD46 processing: A means of expression

Immunobiology

Volumn 217, Issue 2, 2012, Pages 169-175

  Ni Choileain, Siobhan ^a   Astier, Anne L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CD46; Enzymatic processing; Gamma secretase; Matrix metalloproteinases; T cells

Indexed keywords

LIGAND; MEMBRANE COFACTOR PROTEIN;

ANTIGEN PRESENTATION; CELL FUNCTION; ENZYME REGULATION; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD46; COMPLEMENT ACTIVATION; HUMANS; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; PRESENILINS; T-LYMPHOCYTES, REGULATORY;

EID: 84855263699     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.06.003     Document Type: Review

References (109)

1. Alford S.K., Longmore G.D., Stenson W.F., Kemper C. CD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells. J. Immunol. 2008, 181:2544-2555.
2. Alvarez-Lafuente R., De Las Heras V., Bartolome M., Garcia-Montojo M., Arroyo R. Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol. 2006, 16:20-27.
3. Astier A., Trescol-Biemont M.C., Azocar O., Lamouille B., Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 2000, 164:6091-6095.
4. Astier A.L. T-cell regulation by CD46 and its relevance in multiple sclerosis. Immunology 2008, 124:149-154.
5. Astier A.L., Meiffren G., Freeman S., Hafler D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 2006, 116:3252-3257.
6. Berti R., Brennan M.B., Soldan S.S., Ohayon J.M., Casareto L., McFarland H.F., Jacobson S. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J. Neurovirol. 2002, 8:250-256.
7. Blom A.M., Berggard K., Webb J.H., Lindahl G., Villoutreix B.O., Dahlback B. Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins. J. Immunol. 2000, 164:5328-5336.
8. Buchholz C.J., Gerlier D., Hu A., Cathomen T., Liszewski M.K., Atkinson J.P., Cattaneo R. Selective expression of a subset of measles virus receptor-competent CD46 isoforms in human brain. Virology 1996, 217:349-355.
9. Capasso M., Durrant L.G., Stacey M., Gordon S., Ramage J., Spendlove I. Costimulation via CD55 on human CD4+ T cells mediated by CD97. J. Immunol. 2006, 177:1070-1077.
10. Cardone J., Le Friec G., Vantourout P., Roberts A., Fuchs A., Jackson I., Suddason T., Lord G., Atkinson J.P., Cope A., Hayday A., Kemper C. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 2010, 11:862-871.
11. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 2004, 78:4385-4388.
12. Cermelli C., Berti R., Soldan S.S., Mayne M., D'Ambrosia J.M., Ludwin S.K., Jacobson S. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J. Infect. Dis. 2003, 187:1377-1387.
13. Cole D.S., Hughes T.R., Gasque P., Morgan B.P. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. Mol. Immunol. 2006, 43:1953-1964.
14. Coussens A., Timms P.M., Boucher B.J., Venton T.R., Ashcroft A.T., Skolimowska K.H., Newton S.M., Wilkinson K.A., Davidson R.N., Griffiths C.J., Wilkinson R.J., Martineau A.R. 1alpha, 25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009, 127:539-548.
15. Crimeen-Irwin B., Ellis S., Christiansen D., Ludford-Menting M.J., Milland J., Lanteri M., Loveland B.E., Gerlier D., Russell S.M. Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis. J. Biol. Chem. 2003, 278:46927-46937.
16. Elward K., Griffiths M., Mizuno M., Harris C.L., Neal J.W., Morgan B.P., Gasque P. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 2005, 280:36342-36354.
17. Fernandez-Centeno E., de Ojeda G., Rojo J.M., Portoles P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J. Immunol. 2000, 164:4533-4542.
18. Fleischli C., Verhaagh S., Havenga M., Sirena D., Schaffner W., Cattaneo R., Greber U.F., Hemmi S. The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35. J. Virol. 2005, 79:10013-10022.
19. Fogdell-Hahn A., Soldan S.S., Shue S., Akhyani N., Refai H., Ahlqvist J., Jacobson S. Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients. Virus Res. 2005, 110:57-63.
20. Fremeaux-Bacchi V., Moulton E.A., Kavanagh D., Dragon-Durey M.A., Blouin J., Caudy A., Arzouk N., Cleper R., Francois M., Guest G., Pourrat J., Seligman R., Fridman W.H., Loirat C., Atkinson J.P. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2006, 17:2017-2025.
21. Gaggar A., Shayakhmetov D.M., Liszewski M.K., Atkinson J.P., Lieber A. Localization of regions in CD46 that interact with adenovirus. J. Virol. 2005, 79:7503-7513.
22. Gaglia J.L., Mattoo A., Greenfield E.A., Freeman G.J., Kuchroo V.K. Characterization of endogenous Chinese hamster ovary cell surface molecules that mediate T cell costimulation. Cell. Immunol. 2001, 213:83-93.
23. Geis N., Zell S., Rutz R., Li W., Giese T., Mamidi S., Schultz S., Kirschfink M. Inhibition of membrane complement inhibitor expression (CD46, CD55 CD59) by siRNA sensitizes tumor cells to complement attack in vitro. Curr. Cancer Drug Targets 2010, 10:922-931.
24. Ghannam A., Pernollet M., Fauquert J.L., Monnier N., Ponard D., Villiers M.B., Peguet-Navarro J., Tridon A., Lunardi J., Gerlier D., Drouet C. Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells. J. Immunol. 2008, 181:5158-5166.
25. Gill D.B., Koomey M., Cannon J.G., Atkinson J.P. Down-regulation of CD46 by piliated Neisseria gonorrhoeae. J. Exp. Med. 2003, 198:1313-1322.
26. Greenstone H.L., Santoro F., Lusso P., Berger E.A. Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function. J. Biol. Chem. 2002, 277:39112-39118.
27. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004, 104:2840-2848.
28. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357:851-862.
29. Hakulinen J., Junnikkala S., Sorsa T., Meri S. Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form. Eur. J. Immunol. 2004, 34:2620-2629.
30. Hakulinen J., Keski-Oja J. ADAM10-mediated release of complement membrane cofactor protein during apoptosis of epithelial cells. J. Biol. Chem. 2006, 281:21369-21376.
31. Hara T., Kuriyama S., Kiyohara H., Nagase Y., Matsumoto M., Seya T. Soluble forms of membrane cofactor protein (CD46 MCP) are present in plasma, tears, and seminal fluid in normal subjects. Clin. Exp. Immunol. 1992, 89:490-494.
32. Hara T., Suzuki Y., Nakazawa T., Nishimura H., Nagasawa S., Nishiguchi M., Matsumoto M., Hatanaka M., Kitamura M., Seya T. Post-translational modification and intracellular localization of a splice product of CD46 cloned from human testis: role of the intracellular domains in O-glycosylation. Immunology 1998, 93:546-555.
33. Harris C.L., Mizuno M., Morgan B.P. Complement and complement regulators in the male reproductive system. Mol. Immunol. 2006, 43:57-67.
34. Ingram G., Bugert J.J., Loveless S., Robertson N.P. Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity. Eur. J. Neurol. 2010, 17:1386-1389.
35. Jabara H.H., Angelini F., Brodeur S.R., Geha R.S. Ligation of CD46 to CD40 inhibits CD40 signaling in B cells. Int. Immunol. 2011, 23:215-221.
36. Jimenez-Perianez A., Ojeda G., Criado G., Sanchez A., Pini E., Madrenas J., Rojo J.M., Portoles P. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts. J. Leukoc. Biol. 2005, 78:1386-1396.
37. Johnstone R.W., Loveland B.E., McKenzie I.F. Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 1993, 79:341-347.
38. Johnstone R.W., Russell S.M., Loveland B.E., McKenzie I.F. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol. Immunol. 1993, 30:1231-1241.
39. Joubert P.E., Meiffren G., Gregoire I.P., Pontini G., Richetta C., Flacher M., Azocar O., Vidalain P.O., Vidal M., Lotteau V., Codogno P., Rabourdin-Combe C., Faure M. Autophagy induction by the pathogen receptor CD46. Cell Host Microbe. 2009, 6:354-366.
40. Kallstrom H., Blackmer Gill D., Albiger B., Liszewski M.K., Atkinson J.P., Jonsson A.B. Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell Microbiol. 2001, 3:133-143.
41. Kallstrom H., Liszewski M.K., Atkinson J.P., Jonsson A.B. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 1997, 25:639-647.
42. Karp C.L. Measles: immunosuppression, interleukin-12, and complement receptors. Immunol. Rev. 1999, 168:91-101.
43. Karp C.L., Wysocka M., Wahl L.M., Ahearn J.M., Cuomo P.J., Sherry B., Trinchieri G., Griffin D.E. Mechanism of suppression of cell-mediated immunity by measles virus [published erratum appears in Science 1997 February 21;275(5303):1053]. Science 1996, 273:228-231.
44. Kawano M., Seya T., Koni I., Mabuchi H. Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 1999, 116:542-546.
45. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
46. Kemper C., Chan A.C., Green J.M., Brett K.A., Murphy K.M., Atkinson J.P. Activation of human CD4(+) cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421:388-392.
47. Kurita-Taniguchi M., Fukui A., Hazeki K., Hirano A., Tsuji S., Matsumoto M., Watanabe M., Ueda S., Seya T. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46. J. Immunol. 2000, 165:5143-5152.
48. Le Friec G., Kemper C. Complement: coming full circle. Arch. Immunol. Ther. Exp. (Warsz.) 2009, 57:393-407.
49. Lee S.W., Bonnah R.A., Higashi D.L., Atkinson J.P., Milgram S.L., So M. CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae. J. Cell Biol. 2002, 156:951-957.
50. Li K., Feito M.J., Sacks S.H., Sheerin N.S. CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. J. Immunol. 2006, 177:2543-2551.
51. Lindsey J.W., Hatfield L.M. Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivity. J. Neuroimmunol. 2010, 229:238-242.
52. Liszewski M.K., Atkinson J.P. Membrane cofactor protein. Curr. Top. Microbiol. Immunol. 1992, 178:45-60.
53. Liszewski M.K., Atkinson J.P. Membrane cofactor protein (MCP; CD46) Isoforms differ in protection against the classical pathway of complement. J. Immunol. 1996, 156:4415-4421.
54. Liszewski M.K., Leung M., Cui W., Subramanian V.B., Parkinson J., Barlow P.N., Manchester M., Atkinson J.P. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J. Biol. Chem. 2000, 275:37692-37701.
55. Liszewski M.K., Leung M.K., Atkinson J.P. Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. J. Immunol. 1998, 161:3711-3718.
56. Longhi M.P., Harris C.L., Morgan B.P., Gallimore A. Holding T cells in check - a new role for complement regulators?. Trends Immunol. 2006, 27:102-108.
57. Lovkvist L., Sjolinder H., Wehelie R., Aro H., Norrby-Teglund A., Plant L., Jonsson A.B. CD46 Contributes to the severity of group A streptococcal infection. Infect. Immun. 2008, 76:3951-3958.
58. Lublin D.M., Liszewski M.K., Post T.W., Arce M.A., Le Beau M.M., Rebentisch M.B., Lemons L.S., Seya T., Atkinson J.P. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J. Exp. Med. 1988, 168:181-194.
59. Ludford-Menting M.J., Crimeen-Irwin B., Oliaro J., Pasam A., Williamson D., Pedersen N., Guillaumot P., Christansen D., Manie S., Gaus K., Russell S.M. The reorientation of T-cell polarity and inhibition of immunological synapse formation by CD46 involves its recruitment to lipid rafts. J. Lipids 2011, 2011:521863.
60. Ludford-Menting M.J., Thomas S.J., Crimeen B., Harris L.J., Loveland B.E., Bills M., Ellis S., Russell S.M. A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization. J. Biol. Chem. 2002, 277:4477-4484.
61. Ma A., Xiong Z., Hu Y., Qi S., Song L., Dun H., Zhang L., Lou D., Yang P., Zhao Z., Wang X., Zhang D., Daloze P., Chen H. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4+CD25+ regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys. Int. Immunopharmacol. 2009, 9:599-608.
62. Maghzi A.H., Marta M., Bosca I., Etemadifar M., Dobson R., Maggiore C., Giovannoni G., Meier U.C. Viral pathophysiology of multiple sclerosis: a role for Epstein-Barr virus infection?. Pathophysiology 2011, 18:13-20.
63. Mahtout H., Chandad F., Rojo J.M., Grenier D. Porphyromonas gingivalis mediates the shedding and proteolysis of complement regulatory protein CD46 expressed by oral epithelial cells. Oral. Microbiol. Immunol. 2009, 24:396-400.
64. Manchester M., Gairin J.E., Patterson J.B., Alvarez J., Liszewski M.K., Eto D.S., Atkinson J.P., Oldstone M.B. Measles virus recognizes its receptor CD46, via two distinct binding domains within SCR1-2. Virology 1997, 233:174-184.
65. Marie J.C., Astier A.L., Rivailler P., Rabourdin-Combe C., Wild T.F., Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 2002, 3:659-666.
66. Martinez-Forero I., Garcia-Munoz R., Martinez-Pasamar S., Inoges S., Lopez-Diaz de Cerio A., Palacios R., Sepulcre J., Moreno B., Gonzalez Z., Fernandez-Diez B., Melero I., Bendandi M., Villoslada P. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur. J. Immunol. 2008, 38:576-586.
67. McGeachy M.J., Chen Y., Tato C.M., Laurence A., Joyce-Shaikh B., Blumenschein W.M., McClanahan T.K., O'Shea J.J., Cua D.J. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 2009, 10:314-324.
68. Morgan B.P., Marchbank K.J., Longhi M.P., Harris C.L., Gallimore A.M. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 2005, 97:171-179.
69. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 1993, 67:6025-6032.
70. Ni Choileain S., Astier A.L. CD46 plasticity and its inflammatory bias in multiple sclerosis. Arch. Immunol. Ther. Exp. (Warsz.) 2011, 59:49-59.
71. Ni Choileain S., Stephen J., Weller B., Astier A. CD46 Chemotaxis and MS - Are These Linked? 2011, Nova Science Publishers Inc., New York, pp. 85-108.
72. Ni Choileain S., Weyand N.J., Neumann C., Thomas J., So M., Astier A.L. The dynamic processing of CD46 intracellular domains provides a molecular rheostat for T cell activation. PLoS One 2011, 6:e16287.
73. Ni Choileain S., Weyand N.J., So M., Weller B., Photiou D., Astier A.L. Dysregulated control of expression of CD46 cytoplasmic isoforms in T cells from patients with multiple sclerosis. Eur. J. Immunol. 2009, 39:S487. Abstract ECI 2009.
74. Noris M., Brioschi S., Caprioli J., Todeschini M., Bresin E., Porrati F., Gamba S., Remuzzi G. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003, 362:1542-1547.
75. Oliaro J., Pasam A., Waterhouse N.J., Browne K.A., Ludford-Menting M.J., Trapani J.A., Russell S.M. Ligation of the cell surface receptor CD46, alters T cell polarity and response to antigen presentation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18685-18690.
76. Parks A.L., Curtis D. Presenilin diversifies its portfolio. Trends Genet. 2007, 23:140-150.
77. Persson B.D., Schmitz N.B., Santiago C., Zocher G., Larvie M., Scheu U., Casasnovas J.M., Stehle T. Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog. 2011, 6.
78. Pinter C., Beltrami S., Caputo D., Ferrante P., Clivio A. Presence of autoantibodies against complement regulatory proteins in relapsing-remitting multiple sclerosis. J. Neurovirol. 2000, 6(Suppl. 2):S42-S46.
79. Price J.D., Schaumburg J., Sandin C., Atkinson J.P., Lindahl G., Kemper C. Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein. J. Immunol. 2005, 175:677-684.
80. Purcell D.F., Russell S.M., Deacon N.J., Brown M.A., Hooker D.J., McKenzie I.F. Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation. Immunogenetics 1991, 33:335-344.
81. Richards A., Kemp E.J., Liszewski M.K., Goodship J.A., Lampe A.K., Decorte R., Muslumanoglu M.H., Kavukcu S., Filler G., Pirson Y., Wen L.S., Atkinson J.P., Goodship T.H. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:12966-12971.
82. Riley R.C., Kemper C., Leung M., Atkinson J.P. Characterization of human membrane cofactor protein (MCP; CD46) on spermatozoa. Mol. Reprod. Dev. 2002, 62:534-546.
83. Riley-Vargas R.C., Gill D.B., Kemper C., Liszewski M.K., Atkinson J.P. CD46: expanding beyond complement regulation. Trends Immunol. 2004, 25:496-503.
84. Rudd C.E., Schneider H. Unifying concepts in CD28 ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 2003, 3:544-556.
85. Russell S.M., Loveland B.E., Johnstone R.W., Thorley B.R., McKenzie I.F. Functional characterisation of alternatively spliced CD46 cytoplasmic tails. Transplant Proc. 1992, 24:2329-2330.
86. Russell S. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function. Tissue Antigens 2004, 64:111-118.
87. Sakurai F., Akitomo K., Kawabata K., Hayakawa T., Mizuguchi H. Downregulation of human CD46 by adenovirus serotype 35 vectors. Gene Ther. 2007, 14:912-919.
88. Sanchez A., Feito M.J., Rojo J.M. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur. J. Immunol. 2004, 34:2439-2448.
89. Schneider-Schaulies J., Schneider-Schaulies S. Receptor interactions, tropism, and mechanisms involved in morbillivirus-induced immunomodulation. Adv. Virus Res. 2008, 71:173-205.
90. Serafini B., Severa M., Columba-Cabezas S., Rosicarelli B., Veroni C., Chiappetta G., Magliozzi R., Reynolds R., Coccia E.M., Aloisi F. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J. Neuropathol. Exp. Neurol. 2010, 69:677-693.
91. Seya T., Hara T., Iwata K., Kuriyama S., Hasegawa T., Nagase Y., Miyagawa S., Matsumoto M., Hatanaka M., Atkinson J.P., et al. Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera. Int. Immunol. 1995, 7:727-736.
92. Seya T., Hirano A., Matsumoto M., Nomura M., Ueda S. Human membrane cofactor protein (MCP CD46): multiple isoforms and functions. Int. J. Biochem. Cell Biol. 1999, 31:1255-1260.
93. Seya T., Turner J.R., Atkinson J.P. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 1986, 163:837-855.
94. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2002, 2:116-126.
95. Smith A., Santoro F., Di Lullo G., Dagna L., Verani A., Lusso P. Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003, 102:2877-2884.
96. Soldan S.S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P.A., Brennan M.B., Maloni H.W., McFarland H.F., Lin H.C., Patnaik M., Jacobson S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 1997, 3:1394-1397.
97. Soldan S.S., Fogdell-Hahn A., Brennan M.B., Mittleman B.B., Ballerini C., Massacesi L., Seya T., McFarland H.F., Jacobson S. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann. Neurol. 2001, 50:486-493.
98. Tang H., Kawabata A., Takemoto M., Yamanishi K., Mori Y. Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology 2008, 378:265-271.
99. Tuke P.W., Hawke S., Griffiths P.D., Clark D.A. Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains. Mult. Scler. 2004, 10:355-359.
100. Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 2006, 176:7768-7774.
101. Vaknin-Dembinsky A., Murugaiyan G., Hafler D.A., Astier A.L., Weiner H.L. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J. Neuroimmunol. 2008, 195:140-145.
102. Van Den Berg C.W., De Andrade R.M., Magnoli F.C., Marchbank K.J., Tambourgi D.V. Loxosceles spider venom induces metalloproteinase mediated cleavage of MCP/CD46 and MHCI and induces protection against C-mediated lysis. Immunology 2002, 107:102-110.
103. Weyand N.J., Calton C.M., Higashi D.L., Kanack K.J., So M. Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection. J. Immunol. 2010, 184:694-701.
104. Wong T.C., Yant S., Harder B.J., Korte-Sarfaty J., Hirano A. The cytoplasmic domains of complement regulatory protein CD46 interact with multiple kinases in macrophages. J. Leukoc. Biol. 1997, 62:892-900.
105. Xing P.X., Russell S., Prenzoska J., McKenzie I. Discrimination between alternatively spliced STP-A and -B isoforms of CD46. Immunology 1994, 83:122-127.
106. Xu Y.Q., Gao Y.D., Yang J., Guo W. A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients. J. Asthma 2010, 47:367-373.
107. Yant S., Hirano A., Wong T.C. Identification of a cytoplasmic Tyr-X-X-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection. J. Virol. 1997, 71:766-770.
108. Yao K., Graham J., Akahata Y., Oh U., Jacobson S. Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding. J. Neuroimmune Pharmacol. 2010, 5:469-478.
109. Zaffran Y., Destaing O., Roux A., Ory S., Nheu T., Jurdic P., Rabourdin-Combe C., Astier A.L. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 2001, 167:6780-6785.